Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    

HOSPIRA, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on HOSPIRA, INC.
2015HOSPIRA : Announces First Installation of Plum 360™ Infusion System With H..
PU
2015HOSPIRA : Announces First Installation of Plum 360(TM) Infusion System With Hosp..
PR
2015PFIZER : Buy of Hospira Gets Green Light
DJ
2015PFIZER : Gets U.S. Approval to Acquire Hospira, With Divestitures
DJ
2015HOSPIRA : Expert committee BACKS Hospira’s InflectraTM
PU
2015HOSPIRA : Charleston Area Medical Center Integrates Smart Pump Technology to Adv..
PR
2015HOSPIRA : TGA Approves First mAb Biosimilar
PR
2015HOSPIRA : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Int..
PU
2015PFIZER : Gets EU Green Light for Hospira Merger
DJ
2015HOSPIRA : Pfizer wins EU approval for $15 billion Hospira buy
RE
2015PFIZER : Hospira Merger Gets EU Green Light
DJ
2015HOSPIRA : Earnings Beat on Strength in Specialty Injectables -- Update
DJ
2015HOSPIRA : Earnings Beat on Strength in Specialty Injectables
DJ
2015Merck Earnings Hurt by Arthritis Drug Knockoffs
DJ
2015PFIZER : Boosts Its Earnings Outlook -- Update
DJ
2015PFIZER : Boosts Its Earnings Outlook
DJ
2015PFIZER : Boosts Its Earnings Outlook
DJ
2015Mylan independence from Teva's embrace comes with a price
RE
2015HOSPIRA : Announces U.S. Launch of Generic Bivalirudin for Injection
PR
2015HOSPIRA : to Announce Second-Quarter 2015 Results on July 29, 2015
PR
2015HOSPIRA : Pfizer offers concessions in bid to win EU okay for Hospira deal
RE
2015Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
RE
2015HOSPIRA : New results from first real-world study show comparable effectiveness ..
PU
2015HOSPIRA : New results from first real-world study show comparable effectiveness ..
PR
2015HOSPIRA : ANVISA Approves First Infliximab Biosimilar in Brazil
PU
2015HOSPIRA : Alliance for Health Reform Bring Food and Drug Administration, Industr..
PR
2015PFIZER : Receives Second Request From FTC
DJ
2015PFIZER : Receives Second Request From FTC Over Hospira Deal
DJ
2015HOSPIRA : Shareholders Approve Merger of Hospira and Pfizer at Special Meeting
PR
2015Alexion to bolster rare disease offering with $8.4 billion deal
RE
2015HOSPIRA : Statement On FDA's Final Biosimilar Guidance Documents
PU
2015PFIZER : Trims Outlook on Stronger Dollar -- Update
DJ
2015HOSPIRA : Profit Easily Tops Expectations as Injectables Remain Strong
DJ
2015PFIZER : Merck and Bristol-Myers Squibb Report Solid Results
DJ
2015PFIZER : Trims Outlook on Stronger Dollar
DJ
2015HOSPIRA : Leadership Presents at Preeminent European Biosimilars Forum, Announce..
PR
2015Banks see talent flee amid healthcare M&A boom
RE
2015HOSPIRA : Hope for Greater Access for Patients to Biosimilar Medicines
PR
2015Generic drugmaker Mylan offers $29 billion for Perrigo
RE
2015HOSPIRA : to Announce First-Quarter 2015 Results on April 28, 2015
PR
2015HOSPIRA : Gets Warning Letter on Quality Issues at Italy Plant
DJ
2015HOSPIRA : INFLECTRA(TM) (Infliximab) Now Available in Canada
PR
2015HOSPIRA : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates..
PR
2015HOSPIRA : Inflectra™ (infliximab) patient registry reports interim results..
PU
2015HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
PR
2015AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
RE
2015Biotech buys get pharma M&A off to flying start in 2015
RE
2015AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
RE
2015Generic Copies of Remicade Go on Sale in Europe
DJ
2015Biosimilar copies of blockbuster drug launch in major EU markets
RE
2015HOSPIRA : Inflectra(TM) (infliximab) patient registry reports interim results in..
PR
2015HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
BU
2015HOSPIRA : SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of..
BU
2015HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra™ (..
PU
2015HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra(TM) (inf..
PR
2015HOSPIRA : Painkiller in Short Supply Following Hospira Recall -- Update
DJ
2015HOSPIRA : Profit Tops Expectations on Injectables Strength
DJ
2015HOSPIRA : Reports Fourth-Quarter and Full-Year 2014 Results
PR
2015HOSPIRA : SHAREHOLDER ALERT: The Law Offices of Vincent Wong Commences an Invest..
BU
2015HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
BU
2015HOSPIRA : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr..
BU
2015HOSPIRA : Acquisition By Pfizer Inc. May Not Be In The Best Interest of HSP Shar..
PR
2015HOSPIRA : Pfenex And Hospira Announce Collaboration To Develop And Commercialize..
PR
2015HOSPIRA : Harwood Feffer LLP : Announces Investigation of Hospira, Inc.
PR
2015HOSPIRA : Cancels Previously Scheduled Conference Call to Discuss Fourth-Quarter..
PR
2015HOSPIRA : Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR
2015HOSPIRA : UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Launches an Investigati..
BU
2015HOSPIRA : SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investi..
PR
2015HOSPIRA : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr..
BU
2015HOSPIRA : Ryan & Maniskas, LLP : Announces Investigation of Hospira Inc.
PR
2015HOSPIRA : INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of th..
PR
2015HOSPIRA : Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Invest..
PR
2015Pfizer to buy Hospira for $15 billion to bolster hospital products
RE
2015Pfizer's Hospira deal bets on price spike for specialty generics
RE
2015HOSPIRA : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf ..
BU
1  2  3  4  5Next
Chart HOSPIRA, INC.
Duration : Period :
Hospira, Inc. Technical Analysis Chart | US4410601003 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Zena G. Kaufman Senior Vice President-Quality
Paul Greenland Vice President-Biologics
Sector and Competitors